Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SCH 23390 is a halobenzazepine that acts as a selective antagonist of the dopamine D1-
WARNING This product is not for human or veterinary use.
1. SCH 23390: The first selective dopamine D1-
2. Dopamine D1-
3. Atypical antipsychotics and dopamine D1 receptor agonism: An in vivo experimental study using core temperature measurements in the rat. J. Pharmacol. Exp. Ther. 292(2), 731-736 (2000).
4. Differential regulation of the endocannabinoids anandamide and 2-
5. D5 dopamine receptor regulation of phospholipase D. Am. J. Physiol. Heart Circ. Physiol. 288(1), H55-H61 (2005).